Bleeding and Thrombotic Events in Hemodialysis Patients with Atrial Fibrillation on Anticoagulation and Antiplatelet Therapy: A 24-Month Cohort Study
<i>Background and Objectives</i>: Patients undergoing chronic hemodialysis (HD) are predisposed to both thrombotic and bleeding complications due to the complex interplay of end-stage renal disease (ESRD), cardiovascular comorbidities, and the routine use of anticoagulant and antiplatele...
Saved in:
| Main Authors: | Zorica M. Dimitrijevic, Branka P. Mitic, Danijela D. Tasic, Tamara Vrecic, Karolina Paunovic, Sonja Salinger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/60/11/1760 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of regional citrate anticoagulation to patients with hemodialysis at high risk of bleeding
by: WANG Kui, et al.
Published: (2018-01-01) -
Comparative observation of anticoagulant effect of simplified-regional citrate and argatroban in patients with hemodialysis at high risk of bleeding
by: QIU De-jun, et al.
Published: (2020-01-01) -
Observation of the efficacy of long-term citrate anticoagulation in patients with maintenance hemodialysis
by: ZHUANG Feng, et al.
Published: (2020-01-01) -
Factor XI inhibitors are the novel promising anticoagulants in the treatment of age related thrombotic disease
by: Dandan Feng, et al.
Published: (2025-05-01) -
Compassionate Use of Osocimab in Preventing Thrombotic Complications Without Incremental Bleeding: A Case Report
by: Jan Beyer-Westendorf, et al.
Published: (2025-01-01)